Home > Boards > US OTC > Medical - Drugs > Revive Therapeutics Ltd (RVVTF)

Gangrene, Hearing Loss Show Delta Variant May Be

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Giovanni Member Profile
Member Level 
Followed By 80
Posts 15,260
Boards Moderated 0
Alias Born 05/15/01
160x600 placeholder
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trialfor Bucillamine in COVID-19 InvestorsHub NewsWire - 7/15/2021 2:47:32 PM
Revive Therapeutics provides update on late-stage bucillamine COVID-19 trial Seeking Alpha - 7/15/2021 1:44:58 PM
Revive Therapeutics Approved to Trade on the OTCQB Market InvestorsHub NewsWire - 6/28/2021 8:00:00 AM
Revive Therapeutics gets approval to trade on OTCQB Market Seeking Alpha - 6/25/2021 3:56:50 PM
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics InvestorsHub NewsWire - 6/17/2021 8:59:57 AM
Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India InvestorsHub NewsWire - 6/8/2021 9:12:52 AM
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip InvestorsHub NewsWire - 5/17/2021 9:48:35 AM
Revive Therapeutics inks feasibility agreement with LTS Lohmann Seeking Alpha - 5/17/2021 9:30:38 AM
Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19 InvestorsHub NewsWire - 5/3/2021 9:32:33 AM
Revive inks research agreement to explore use of Bucillamine in treating severe COVID-19 Seeking Alpha - 5/3/2021 9:27:48 AM
Revive Therapeutics Files For FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury InvestorsHub NewsWire - 4/27/2021 9:51:20 AM
Revive files for FDA orphan drug status for psilocybin in traumatic brain injury Seeking Alpha - 4/27/2021 9:33:08 AM
Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional ....cont InvestorsHub NewsWire - 4/22/2021 8:26:06 AM
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 InvestorsHub NewsWire - 3/24/2021 9:15:00 AM
Revive Therapeutics provides update on late-stage Bucillamine study in COVID-19 Seeking Alpha - 3/24/2021 9:08:15 AM
Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of ...Cont InvestorsHub NewsWire - 3/19/2021 7:56:39 AM
Revive Therapeutics posts positive data from pre-clinical psilocybin brain injury study Seeking Alpha - 3/19/2021 7:37:00 AM
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion...Cont InvestorsHub NewsWire - 2/26/2021 9:01:27 AM
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion...Cont InvestorsHub NewsWire - 2/26/2021 9:01:27 AM
Revive Therapeutics Acquires Unique Psilocybin Assets InvestorsHub NewsWire - 2/17/2021 9:53:14 AM
Revive Therapeutics acquires psilocybin assets for C$10M Seeking Alpha - 2/17/2021 9:38:20 AM
Revive Therapeutics Provides Update on Cannabinoid Pharmaceuticals Program InvestorsHub NewsWire - 2/11/2021 8:05:24 AM
Revive Therapeutics in Phase 3 clinical trial for COVID-19 treatment InvestorsHub NewsWire - 1/27/2021 8:13:52 AM
How Combat Sports Are Researching Micro-Dosing Psychedelics To Treat Brain Injuries InvestorsHub NewsWire - 1/18/2021 9:51:54 AM
Revive Therapeutics Announces Research Collaboration with North Carolina State University InvestorsHub NewsWire - 1/14/2021 8:30:27 AM
Giovanni Member Level  Tuesday, 06/08/21 04:29:01 PM
Re: None
Post # of 27736 
Gangrene, Hearing Loss Show Delta Variant May Be More Severe

By Bhuma Shrivastava

June 7, 2021, 5:00 PM EDT Updated on June 8, 2021, 8:26 AM EDT

Indian doctors seeing unusual symptoms in Covid-19 patients

Data from England suggest it has higher hospitalization risk

The coronavirus variant driving India’s devastating Covid-19 second wave is the most infectious to emerge so far. Doctors now want to know if it’s also more severe.

Hearing impairment, severe gastric upsets and blood clots leading to gangrene, symptoms not typically seen in Covid patients, have been linked by doctors in India to the so-called delta variant. In England and Scotland, early evidence suggests the strain -- which is also now dominant there -- carries a higher risk of hospitalization.
Delta, also known as B.1.617.2, has spread to more than 60 countries over the past six months and triggered travel curbs from Australia to the U.S. A spike in infections, fueled by the variant, has forced U.K. to reconsider its plans for reopening later this month, with a local report saying it may be pushed back by two weeks. Singapore found that the mutation accounted for 95% of the local Covid samples linked to variants of concern. Higher rates of transmission and a reduction in the effectiveness of vaccines have made understanding the strain’s effects especially critical.

Guru Teg Bahadur Covid Care Centre At Gurudwara Sir Rakab Ganj Sahib
A doctor and health workers check an x-ray scan of a Covid-19 patient at an isolation ward in New Delhi on May 25.Photographer: Sonu Mehta/Hindustan Times/Getty Images
“We need more scientific research to analyze if these newer clinical presentations are linked to B.1.617 or not,” said Abdul Ghafur, an infectious disease physician at the Apollo Hospital in Chennai, southern India’s largest city. Ghafur said he is seeing more Covid patients with diarrhea now than in the initial wave of the pandemic.

‘New Enemy’
“Last year, we thought we had learned about our new enemy, but it changed,” Ghafur said. “This virus has become so, so unpredictable.”

Stomach pain, nausea, vomiting, loss of appetite, hearing loss and joint pain are among the ailments Covid patients are experiencing, according to six doctors treating patients across India. The beta and gamma variants -- first detected in South Africa and Brazil respectively -- have shown little or no evidence of triggering unusual clinical signs, according to a study by researchers from the University of New South Wales last month.

Covid-19 Delta Variant Explained

Covid-19 Delta Variant Explained

WATCH: The coronavirus variant that drove India’s Covid-19 epidemic is the most infectious to emerge so far.(Source: Quicktake)
U.K.’s Johnson Faces Lockdown Dilemma as Covid Cases Rise
Melbourne Lockdown Extended on Warning of Virus’ Quick Spread
Fungal Epidemic, Sick Babies: Worst of Covid Plays Out in India
Why the Mutated Coronavirus Variants Are So Worrisome: QuickTake
Some patients develop micro thrombi, or small blood clots, so severe that they led affected tissue to die and develop gangrene, said Ganesh Manudhane, a Mumbai cardiologist, who has treated eight patients for thrombotic complications at the Seven Hills Hospital during the past two months. Two required amputations of fingers or a foot.

“I saw three-to-four cases the whole of last year, and now it’s one patient a week,” Manudhane said.

Baffling Clots
More from
U.S. Eases Travel Warnings; Fauci Warns on Variant: Virus Update
Drugmaker With No Product Gains 910% on Alzheimer’s, Meme Hopes
U.K. Sends Military to Covid Hotspots to Help Tackle Variant
Colorado Legislature Passes Health Care Plan Cutting Costs 15%
India has reported 18.6 million Covid cases thus far in 2021, compared with 10.3 million last year. The delta variant was the “primary cause” behind the country’s deadlier second wave and is 50% more contagious than the alpha strain that was first spotted in the U.K., according to a recent study by an Indian government panel.

The surge in cases may have driven an increase in the frequency with which rare Covid complications are being observed. Even still, Manudhane said he is baffled by the blood clots he’s seeing in patients across age groups with no past history of coagulation-related problems.

“We suspect it could be because of the new virus variant,” he said. Manudhane is collecting data to study why some people develop the clots and others don’t.

Doctors are also finding instances of clots forming in blood vessels that supply the intestines, causing patients to experience stomach pain -- their only symptom, local media have reported.

Some Covid patients are also seeking medical care for hearing loss, swelling around the neck and severe tonsillitis, said Hetal Marfatia, an ear nose and throat surgeon at Mumbai’s King Edward Memorial Hospital.

“Every person is showing different symptoms” in the second wave, she said.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences